In the early days of the pandemic, President Trump made headlines when he reportedly tried to secure rights to a vaccine from German developer CureVac on behalf of the US government—a move that stirred questions about equity and justice. Should the United States get priority access to the Covid vaccine just because we are the world’s wealthiest nation? Shouldn’t the most vulnerable—no matter their nationality or salary—get vaccinated first?
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045